AI assistant
DEXCOM INC — Director's Dealing 2017
Mar 24, 2017
30198_dirs_2017-03-24_400e6d8d-2205-4475-809e-003193f3e415.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2017-03-22
Reporting Person: ROPER JESS (SVP, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-22 | Common Stock | S | 2000 | $75.9683 | Disposed | 8452 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 46497 | Direct |
Footnotes
F1: On November 04, 2016, Mr. Roper adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Roper. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: This transaction was executed in multiple trades at prices ranging from $75.19 to $76.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: Shares are held by the LJR Family Trust U/T/A DTD 08/08/2013, with respect to which the reporting person is a trustee.